Eric D. Slosberg
Impact in
-
- Cancer Genomics and Diagnostics
-
- Cancer-related Molecular Pathways
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 6
- Ubiquitin and proteasome pathways 4
- Retinoids in leukemia and cellular processes 4
- Oncology 13
- Cancer-related Molecular Pathways 3
- Colorectal Cancer Treatments and Studies 3
- Co-authors
- I. Bernard Weinstein (7 shared papers)Yao Yao (3 shared papers)Shari L. Caplan (2 shared papers)Michael Kaleko (2 shared papers)Sheila Connelly (2 shared papers)Brian R. Boettcher (2 shared papers)Jae Won Soh (2 shared papers)Ira Schieren (2 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Oncogene (5 papers)Diabetes (2 papers)Annals of Oncology (2 papers)Molecular Carcinogenesis (2 papers)
- Partner nations
- United StatesChinaHong Kong
In The Last Decade
Eric D. Slosberg
27 papers receiving 645 citations
Peers
Comparison fields: 5 of 75
- Cancer Research 92
- Oncology 163
- Molecular Biology 356
- Endocrinology, Diabetes and Metabolism 50
- Immunology and Allergy 17
Countries citing papers authored by Eric D. Slosberg
This map shows the geographic impact of Eric D. Slosberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric D. Slosberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric D. Slosberg more than expected).
Fields of papers citing papers by Eric D. Slosberg
This network shows the impact of papers produced by Eric D. Slosberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric D. Slosberg. The network helps show where Eric D. Slosberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric D. Slosberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 67 | |
| 2 | 1999 | 63 | |
| 3 | 1999 | 63 | |
| 4 | 1998 | 62 | |
| 5 | 2001 | 59 | |
| 6 | 2001 | 50 | |
| 7 | 2000 | 46 | |
| 8 | 2005 | 34 | |
| 9 | 2018 | 32 | |
| 10 | 1999 | 29 | |
| 11 | The protein kinase C beta-specific inhibitor LY379196 blocks TPA-induced monocytic differentiation of HL60 cells the protein kinase C beta-specific inhibitor LY379196 blocks TPA-induced monocytic differentiation of HL60 cells. | 2000 | 26 |
| 12 | 1997 | 24 | |
| 13 | 2000 | 24 | |
| 14 | 2015 | 23 | |
| 15 | 2015 | 9 | |
| 16 | 2015 | 9 | |
| 17 | 2020 | 8 | |
| 18 | 2016 | 6 | |
| 19 | 2016 | 6 | |
| 20 | 2020 | 4 |
About Eric D. Slosberg
Eric D. Slosberg is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Cell Biology, having authored 30 papers that have together received 658 indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (6 papers), Cancer Genomics and Diagnostics (5 papers), Lung Cancer Treatments and Mutations (5 papers), Ubiquitin and proteasome pathways (4 papers), Retinoids in leukemia and cellular processes (4 papers), Advanced Breast Cancer Therapies (4 papers), Cancer-related Molecular Pathways (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). The work is most often cited by research in Cancer Research (92 citations), Oncology (163 citations), Molecular Biology (356 citations), Endocrinology, Diabetes and Metabolism (50 citations) and Immunology and Allergy (17 citations). Eric D. Slosberg has collaborated with scholars based in United States, China and Hong Kong. Frequent co-authors include I. Bernard Weinstein, Yao Yao, Shari L. Caplan, Michael Kaleko, Sheila Connelly, Brian R. Boettcher, Jae Won Soh, Ira Schieren, Yuichiro� Doki and Michael G. Klein. Their work appears in journals such as Journal of Clinical Oncology, Oncogene, Diabetes, Annals of Oncology and Molecular Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.